Cequent Pharmaceuticals, Inc is developing new
clinically compatible RNAi-based therapies.
05 May 2008
Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals’ Board of Directors. Click Here for Press Release
01 August 2007
Animation on tkRNAi is Now Available for Viewing
Home | Company | People | Research | Partners | Media | Contact
Legal Notice | Privacy Policy | Site Map
